Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 4
2019 2
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents.
Liu CF, Shen QK, Li JJ, Tian YS, Quan Z. Liu CF, et al. J Enzyme Inhib Med Chem. 2017 Dec;32(1):1111-1119. doi: 10.1080/14756366.2017.1344982. J Enzyme Inhib Med Chem. 2017. PMID: 28791908 Free PMC article.
Design and synthesis of novel oridonin analogues as potent anticancer agents.
Shen QK, Chen ZA, Zhang HJ, Li JL, Liu CF, Gong GH, Quan ZS. Shen QK, et al. J Enzyme Inhib Med Chem. 2018 Dec;33(1):324-333. doi: 10.1080/14756366.2017.1419219. J Enzyme Inhib Med Chem. 2018. PMID: 29303372 Free PMC article.
Synthesis, and evaluation of in vitro and in vivo anticancer activity of 14-substituted oridonin analogs: A novel and potent cell cycle arrest and apoptosis inducer through the p53-MDM2 pathway.
Shen QK, Deng H, Wang SB, Tian YS, Quan ZS. Shen QK, et al. Eur J Med Chem. 2019 Jul 1;173:15-31. doi: 10.1016/j.ejmech.2019.04.005. Epub 2019 Apr 6. Eur J Med Chem. 2019. PMID: 30981113
Discovery and evaluation of novel synthetic 5-alkyl-4-oxo-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoxaline-1-carbox-amide derivatives as anti-inflammatory agents.
Shen QK, Gong GH, Li G, Jin M, Cao LH, Quan ZS. Shen QK, et al. J Enzyme Inhib Med Chem. 2020 Dec;35(1):85-95. doi: 10.1080/14756366.2019.1680658. J Enzyme Inhib Med Chem. 2020. PMID: 31707866 Free PMC article.